D-limonene exhibits anti-inflammatory and antioxidant properties in an ulcerative colitis rat model via regulation of iNOS, COX-2, PGE2 and ERK signaling pathways

  • Authors:
    • Lihua Yu
    • Jing Yan
    • Zhiguang Sun
  • View Affiliations

  • Published online on: February 22, 2017     https://doi.org/10.3892/mmr.2017.6241
  • Pages: 2339-2346
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

D-limonene has been demonstrated to have important immunomodulatory properties, including antitumor effects, and may alleviate asthma and allergies. In the present study, the anti‑inflammatory effects of D‑limonene were investigated in an ulcerative colitis (UC) rat model. Healthy male Sprague‑Dawley rats were randomly divided into control, untreated UC, and treatment with 50 or 100 mg/kg D‑limonene UC groups. In UC rats, disease activity and colonic mucosa damage were significantly reduced by the anti‑inflammatory effects of D‑limonene, via suppression of matrix metalloproteinase (MMP)‑2 and ‑9 gene expression. In addition, treatment with D‑limonene significantly increased antioxidant, inducible nitric oxide synthase (iNOS) and cyclooxygenase‑2 (COX‑2) protein expression levels in UC rats. A decrease in prostaglandin E2 (PGE2) production, transforming growth factor‑β (TGF‑β) gene expression and an increase phosphorylated‑extracellular signal regulated kinase (ERK) 1/2 expression levelswere observed in UC rats treated with D‑limonene. In conclusion, D‑limonene reduced MMP‑2 and ‑9 mRNA expression levels via regulation of the iNOS, COX‑2, PGE2, TGF‑β and ERK1/2 signaling pathways in a UC rat model, indicating its potential antioxidant and anti‑inflammatory properties.

References

1 

Brandse JF, van den Brink GR, Wildenberg ME, van der Kleij D, Rispens T, Jansen JM, Mathôt RA, Ponsioen CY, Löwenberg M and D'Haens GR: Loss of infliximab into feces is associated with lack of response to therapy in patients with severe ulcerative colitis. Gastroenterology. 149:350–355.e2. 2015. View Article : Google Scholar : PubMed/NCBI

2 

Boschetti G, Nancey S, Moussata D, Stefanescu C, Roblin X, Chauvenet M, Stroeymeyt K, Bouhnik Y and Flourié B: Tacrolimus induction followed by maintenance monotherapy is useful in selected patients with moderate-to-severe ulcerative colitis refractory to prior treatment. Dig Liver Dis. 46:875–880. 2014. View Article : Google Scholar : PubMed/NCBI

3 

Okuyama Y, Andoh A, Nishishita M, Fukunaga K, Kamikozuru K, Yokoyama Y, Ueno Y, Tanaka S, Kuge H, Yoshikawa S, et al: Multicenter prospective study for clinical and endoscopic efficacies of leukocytapheresis therapy in patients with ulcerative colitis. Scand J Gastroenterol. 48:412–418. 2013. View Article : Google Scholar : PubMed/NCBI

4 

Cleynen I, Boucher G, Jostins L, Schumm LP, Zeissig S, Ahmad T, Andersen V, Andrews JM, Annese V, Brand S, et al: Inherited determinants of Crohn's disease and ulcerative colitis phenotypes: A genetic association study. Lancet. 387:156–167. 2016. View Article : Google Scholar : PubMed/NCBI

5 

Heikens JT, De Vries J, De Jong DJ, den Oudsten BL, Hopman W, Groenewoud JM, van der Kolk MB, Gooszen HG and van Laarhoven CJ: Evaluation of long-term function, complications, quality of life and health status after restorative proctocolectomy with ileo neo rectal and with ileal pouch anal anastomosis for ulcerative colitis. Colorectal Dis. 15:e323–e329. 2013. View Article : Google Scholar : PubMed/NCBI

6 

Adedokun OJ, Xu Z, Padgett L, Blank M, Johanns J, Griffiths A, Ford J, Zhou H, Guzzo C, Davis HM and Hyams J: Pharmacokinetics of infliximab in children with moderate-to-severe ulcerative colitis: Results from a randomized, multicenter, open-label, phase 3 study. Inflamm Bowel Dis. 19:2753–2762. 2013. View Article : Google Scholar : PubMed/NCBI

7 

Guardiola J, Lobatón T, Rodríguez-Alonso L, Ruiz-Cerulla A, Arajol C, Loayza C, Sanjuan X, Sánchez E and Rodríguez-Moranta F: Fecal level of calprotectin identifies histologic inflammation in patients with ulcerative colitis in clinical and endoscopic remission. Clin Gastroenterol Hepatol. 12:1865–1870. 2014. View Article : Google Scholar : PubMed/NCBI

8 

Takeda Y, Nakase H, Namba K, Inoue S, Ueno S, Uza N and Chiba T: Upregulation of T-bet and tight junction molecules by Bifidobactrium longum improves colonic inflammation of ulcerative colitis. Inflamm Bowel Dis. 15:1617–1618. 2009. View Article : Google Scholar : PubMed/NCBI

9 

Laake KO, Line PD, Aabakken L, Løtveit T, Bakka A, Eide J, Roseth A, Grzyb K, Bjørneklett A and Vatn MH: Assessment of mucosal inflammation and circulation in response to probiotics in patients operated with ileal pouch anal anastomosis for ulcerative colitis. Scand J Gastroenterol. 38:409–414. 2003. View Article : Google Scholar

10 

Yang SK, Jung HY, Kang GH, Kim YM, Myung SJ, Shim KN, Hong WS and Min YI: Appendiceal orifice inflammation as a skip lesion in ulcerative colitis: An analysis in relation to medical therapy and disease extent. Gastrointest Endosc. 49:743–747. 1999. View Article : Google Scholar : PubMed/NCBI

11 

Mawdsley JE, Jenkins DG, Macey MG, Langmead L and Rampton DS: The effect of hypnosis on systemic and rectal mucosal measures of inflammation in ulcerative colitis. Am J Gastroenterol. 103:1460–1469. 2008. View Article : Google Scholar : PubMed/NCBI

12 

Mannon PJ, Hornung RL, Yang Z, Yi C, Groden C, Friend J, Yao M, Strober W and Fuss IJ: Suppression of inflammation in ulcerative colitis by interferon-b-1a is accompanied by inhibition of IL-13 production. Gut. 60:449–455. 2011. View Article : Google Scholar : PubMed/NCBI

13 

Wilson MJ, Lindgren BR and Sinha AA: The effect of dietary supplementation with limonene or myo-inositol on the induction of neoplasia and matrix metalloproteinase and plasminogen activator activities in accessory sex organs of male Lobund-Wistar rats. Exp Mol Pathol. 85:83–89. 2008. View Article : Google Scholar : PubMed/NCBI

14 

Marmulla R and Harder J: Microbial monoterpene transformations-a review. Front Microbiol. 5:3462014. View Article : Google Scholar : PubMed/NCBI

15 

Rehman MU, Tahir M, Khan AQ, Khan R, Hamiza Oday-O, Lateef A, Hassan SK, Rashid S, Ali N, Zeeshan M and Sultana S: D-limonene suppresses doxorubicin-induced oxidative stress and inflammation via repression of COX-2, iNOS, and NFκB in kidneys of Wistar rats. Exp Biol Med (Maywood). 239:465–476. 2014. View Article : Google Scholar : PubMed/NCBI

16 

Yoon WJ, Lee NH and Hyun CG: Limonene suppresses lipopolysaccharide-induced production of nitric oxide, prostaglandin E2, and pro-inflammatory cytokines in RAW 2647 macrophages. J Oleo Sci. 59:415–421. 2010. View Article : Google Scholar : PubMed/NCBI

17 

Chaudhary SC, Siddiqui MS, Athar M and Alam MS: D-Limonene modulates inflammation, oxidative stress and Ras-ERK pathway to inhibit murine skin tumorigenesis. Hum Exp Toxicol. 31:798–811. 2012. View Article : Google Scholar : PubMed/NCBI

18 

Mao JW, He XM, Tang HY and Wang YD: Protective role of metalloproteinase inhibitor (AE-941) on ulcerative colitis in rats. World J Gastroenterol. 18:7063–7069. 2012. View Article : Google Scholar : PubMed/NCBI

19 

Livak KJ and Schmittgen TD: Analysis of relative gene expression data using real-time quantitative PCR and the 2(−Delta Delta C(T)) Method. Methods. 25:402–408. 2001. View Article : Google Scholar : PubMed/NCBI

20 

Van Assche G, Manguso F, Zibellini M, Cabriada N, uño JL, Goldis A, Tkachenko E, Varoli G, Kleczkowski D, Annese V, D'Heygere F, et al: Oral prolonged release beclomethasone dipropionate and prednisone in the treatment of active ulcerative colitis: Results from a double-blind, randomized, parallel group study. Am J Gastroenterol. 110:708–715. 2015. View Article : Google Scholar : PubMed/NCBI

21 

Trifan A, Stanciu C, Stoica O, Girleanu I and Cojocariu C: Impact of Clostridium difficile infection on inflammatory bowel disease outcome: A review. World J Gastroenterol. 20:11736–11742. 2014. View Article : Google Scholar : PubMed/NCBI

22 

Hirota R, Nakamura H, Bhatti SA, Ngatu NR, Muzembo BA, Dumavibhat N, Eitoku M, Sawamura M and Suganuma N: Limonene inhalation reduces allergic airway inflammation in Dermatophagoides farinae-treated mice. Inhal Toxicol. 24:373–381. 2012. View Article : Google Scholar : PubMed/NCBI

23 

Jorgensen JR and Mortensen PB: Influence of feces from patients with ulcerative colitis on butyrate oxidation in rat colonocytes. Dig Dis Sci. 44:2099–2109. 1999. View Article : Google Scholar : PubMed/NCBI

24 

Alagozlu H, Gorgul A, Bilgihan A, Tuncer C and Unal S: Increased plasma levels of advanced oxidation protein products (AOPP) as a marker for oxidative stress in patients with active ulcerative colitis. Clin Res Hepatol Gastroenterol. 37:80–85. 2013. View Article : Google Scholar : PubMed/NCBI

25 

Keshavarzian A, Banan A, Farhadi A, Komanduri S, Mutlu E, Zhang Y and Fields JZ: Increases in free radicals and cytoskeletal protein oxidation and nitration in the colon of patients with inflammatory bowel disease. Gut. 52:720–728. 2003. View Article : Google Scholar : PubMed/NCBI

26 

Roediger WE: Review article: Nitric oxide from dysbiotic bacterial respiration of nitrate in the pathogenesis and as a target for therapy of ulcerative colitis. Aliment Pharmacol Ther. 27:531–541. 2008. View Article : Google Scholar : PubMed/NCBI

27 

Rizk M, Ibrahim N and El-Rigal N: Comparative in vivo antioxidant levels in Schistosoma mansoni infected mice treated with praziquantel or the essential oil of Melaleuca armillaris leaves. Pak J Biol Sci. 15:971–978. 2012. View Article : Google Scholar : PubMed/NCBI

28 

Zhang CX, Guo LK and Guo XF: Interaction between the polymorphisms of cyclooxygenase-2-1195G/A, MnSOD9Ala/val genes and the high-fat diets and its correlation with ulcerative colitis. Zhongguo Yi Xue Ke Xue Yuan Xue Bao. 37:37–43. 2015.PubMed/NCBI

29 

Hussein I Abdallah Hajj, Freund JN, Reimund JM, Shams A, Yamine M, Leone A and Jurjus AR: Enteropathogenic e.coli sustains iodoacetamide-induced ulcerative colitis-like colitis in rats: Modulation of IL-1β, IL-6, TNF-α, COX-2, and apoptosisi. J Biol Regul Homeost Agents. 26:515–526. 2012.PubMed/NCBI

30 

Fratila OC and Iliaş TI: COX-2 and Ki-67 immunohistochemical markers in the assessment of long-standing ulcerative colitis associated dysplasia. Rom J Morphol Embryol. 54:143–149. 2013.PubMed/NCBI

31 

Roulis M, Nikolaou C, Kotsaki E, Kaffe E, Karagianni N, Koliaraki V, Salpea K, Ragoussis J, Aidinis V, Martini E, et al: Intestinal myofibroblast-specific Tpl2-Cox-2-PGE2 pathway links innate sensing to epithelial homeostasis. Proc Natl Acad Sci USA. 111:E4658–E4667. 2014. View Article : Google Scholar : PubMed/NCBI

32 

Tammali R, Ramana KV and Srivastava SK: Aldose reductase regulates TNF-alpha-induced PGE2 production in human colon cancer cells. Cancer Lett. 252:299–306. 2007. View Article : Google Scholar : PubMed/NCBI

33 

Guan F, Wang H, Shan Y, Chen Y, Wang M, Wang Q, Yin M, Zhao Y, Feng X and Zhang J: Inhibition of COX-2 and PGE in LPS-stimulated RAW264.7 cells by lonimacranthoide VI, a chlorogenic acid ester saponin. Biomed Rep. 2:760–764. 2014.PubMed/NCBI

34 

Li C, Iness A, Yoon J, Grider JR, Murthy KS, Kellum JM and Kuemmerle JF: Noncanonical STAT3 activation regulates excess TGF-β1 and collagen I expression in muscle of stricturing Crohn's disease. J Immunol. 194:3422–3431. 2015. View Article : Google Scholar : PubMed/NCBI

35 

Fleissner D, Frede A, Knott M, Knuschke T, Geffers R, Hansen W, Dobos G, Langhorst J, Buer J and Westendorf AM: Generation and function of immunosuppressive human and murine CD8+ T cells by transforming growth factor-β and retinoic acid. Immunology. 134:82–92. 2011. View Article : Google Scholar : PubMed/NCBI

36 

Setia S, Nehru B and Sanyal SN: Upregulation of MAPK/Erk and PI3K/Akt pathways in ulcerative colitis-associated colon cancer. Biomed Pharmacother. 68:1023–1029. 2014. View Article : Google Scholar : PubMed/NCBI

37 

Dambacher J, Beigel F, Seiderer J, Haller D, Göke B, Auernhammer CJ and Brand S: Interleukin 31 mediates MAP kinase and STAT1/3 activation in intestinal epithelial cells and its expression is upregulated in inflammatory bowel disease. Gut. 56:1257–1265. 2007. View Article : Google Scholar : PubMed/NCBI

38 

Lv Q, Qiao SM, Xia Y, Shi C, Xia YF, Chou GX, Wang ZT, Dai Y and Wei ZF: Norisoboldine ameliorates DSS-induced ulcerative colitis in mice through induction of regulatory T cells in colons. Int Immunopharmacol. 29:787–797. 2015. View Article : Google Scholar : PubMed/NCBI

39 

Rezaie A, Khalaj S, Shabihkhani M, Nikfar S, Zamani MJ, Mohammadirad A, Daryani NE and Abdollahi M: Study on the correlations among disease activity index and salivary transforming growth factor-beta 1 and nitric oxide in ulcerative colitis patients. Ann N Y Acad Sci. 1095:305–314. 2007. View Article : Google Scholar : PubMed/NCBI

40 

Rufino AT, Ribeiro M, Sousa C, Judas F, Salgueiro L, Cavaleiro C and Mendes AF: Evaluation of the anti-inflammatory, anti-catabolic and pro-anabolic effects of E-caryophyllene, myrcene and limonene in a cell model of osteoarthritis. Eur J Pharmacol. 750:141–150. 2015. View Article : Google Scholar : PubMed/NCBI

Related Articles

Journal Cover

April 2017
Volume 15 Issue 4

Print ISSN: 1791-2997
Online ISSN:1791-3004

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
APA
Yu, L., Yan, J., & Sun, Z. (2017). D-limonene exhibits anti-inflammatory and antioxidant properties in an ulcerative colitis rat model via regulation of iNOS, COX-2, PGE2 and ERK signaling pathways. Molecular Medicine Reports, 15, 2339-2346. https://doi.org/10.3892/mmr.2017.6241
MLA
Yu, L., Yan, J., Sun, Z."D-limonene exhibits anti-inflammatory and antioxidant properties in an ulcerative colitis rat model via regulation of iNOS, COX-2, PGE2 and ERK signaling pathways". Molecular Medicine Reports 15.4 (2017): 2339-2346.
Chicago
Yu, L., Yan, J., Sun, Z."D-limonene exhibits anti-inflammatory and antioxidant properties in an ulcerative colitis rat model via regulation of iNOS, COX-2, PGE2 and ERK signaling pathways". Molecular Medicine Reports 15, no. 4 (2017): 2339-2346. https://doi.org/10.3892/mmr.2017.6241